Hum Vaccin Immunother . Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus t

[tetano]

Hum Vaccin Immunother


. 2024 Dec 31;20(1):2402644.
doi: 10.1080/21645515.2024.2402644. Epub 2024 Sep 23. Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial

Yajun Shu[SUP] 1 [/SUP], Zhuoqun Sun[SUP] 2 [/SUP], Fan Gao[SUP] 3 [/SUP], Zhuhang Huang[SUP] 1 [/SUP], Xing Meng[SUP] 4 [/SUP], Shaomin Chen[SUP] 1 [/SUP], Qun Shu[SUP] 5 [/SUP], Lianhao Wang[SUP] 2 [/SUP], Hengming Zhang[SUP] 4 [/SUP], Zhifang Ying[SUP] 3 [/SUP], Jikai Zhang[SUP] 1 [/SUP]



Affiliations

• PMID: 39313857
• PMCID: PMC11423659
• DOI: 10.1080/21645515.2024.2402644

Abstract

NCT04993365 (ClinicalTrials.gov).

Keywords: Co-administration; children; immunogenicity; inactivated COVID-19 vaccine; inactivated EV71 vaccine; safety.

​